A Trial to Learn How a New Liquid Form of Rivaroxaban Behaves and How Safe it is Compared to the Current Tablet Form of Rivaroxaban in Healthy Male Participants

Clinical trial NCT04720092 · COMPLETED

Trial details

NCT number

NCT04720092

Sponsor

Bayer

Status

COMPLETED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2017-07-05

Primary completion

2017-08-28

Enrollment

30

View on ClinicalTrials.gov